Founded in 2017, Cansativa is a GMP-certified pharmaceutical company and holds a GDP pharmaceutical wholesale license to trade in controlled substances. From its headquarter in Moerfelden-Walldorf, Germany, Cansativa and its subsidiaries work to professionalize the medical cannabis market, eliminate stigmatization and to permanently reduce prices for patients. As an owner-managed company, our growth target is linked to a long-term vision - we want to set industry-wide benchmarks.
Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of its industry’s “first movers”, it has become one of the largest independent manufacturers, importers, and distributors of medical cannabis in Germany. From its location in Frankfurt am Main, the company supplies pharmacies and pharmaceutical wholesalers throughout Germany.
Cansativa also offers pharmaceutical companies a platform for market access. We have developed into a full-service provider for the medical cannabis market. Cansativa is a service provider for all aspects of medical cannabis sales: we assist in communicating with authorities, certification processes, project and process management and all matters in the area of regulatory affairs.
The founding team of Cansativa and its subsidiaries continue to expand. We are building on two generations of expertise in medicine, law and strategy as well as technology and medical engineering.
Our team is continuousely working on the professionalization of the medical cannabis market. Highest quality and efficiency for our customers and business partners are our top priority.
Cansativa GmbH distributes as independent wholesale company medical cannabis and medical devices in Germany.
We sell products from the Netherlands and non-European countries. Single sourcing, i.e. the procurement of cannabis from a singular supply source, does not represent a sustainable model on our part. Our medical products comply with the GMP-standard and are manufactured by well-established pharmaceutical manufacturers (at the moment: Bedrocan and Canopy Growth).
As required under German law, we offer detailed scientific information exclusively to expert audiences, such as pharmacists and physicians. If you are eligible to this information, do not hesitate to get in touch.
As a fast growing pharmaceutical company in the medical cannabis market, our goal is to set industry benchmarks by becoming the leading German medical cannabis distributor and offering an own unique product portfolio.
- Two fully licensed EU-GMP and EU-GDP sites in Germany to capture the full potential of a rapidly growing market
- Strong operations track record (Sold over 25,000 units and several hundred kg of medical cannabis)
- Directly connected to 20,000 pharmacies by state-of-the-art end-to-end ERP system
- Fast and continuous scaling net revenue
- Top-notch medical cannabis focused expert inhouse-sales team
- Highly experienced and successful leadership team
Additionally, we already offer highly professional, integrated solutions for the growing medical cannabis market: covering import, in-house manufacturing, company-owned and fully certified narcotics and pharmaceutical warehousing and distribution to wholesalers and pharmacies.
Would you like to invest in Cansativa and its expert team in the medical cannabis field? We look forward to getting in touch!
As fast expanding company we are always looking for qualified and motivated employees who share our passion for innovative medicines and treatment options. We don’t only consider our employees as a success factor, but also as people with their own needs and goals. That is why we make sure that our employees get the possibility to develop themselves in the best way to ensure their satisfaction. As we are looking for German speaking employees only, you will find the job descriptions in German.
Director Beschaffung und Qualität
Zur Unterstützung unseres Teams suchen wir ab sofort für mindestens drei Monate einen motivierten Praktikanten (m/w/d) in Vollzeit. Zur Stellenausschreibung
Now online: our news-blog
In our blog, Cansativa experts write about the latest topics, give information on the medical Cannabis market and share news about Cansativa. Stay tuned!
- First logistics and production site
Cansativa moves into its first certified logistics and production site in Frankfurt.
- Fill and Finish
Cansativa receives the wholesale permit and permission to repack, fill, and recommission medical cannabis in May 2018.
Cansativa sells medical cannabis to pharmacies in Germany since May 2018.
- EU GxP-Hub
Cansativa establishes second logistics and production site as service- and fulfillmentcenter in June 2019.
Cansativa receives EU-GMP-license according to §§ 13, 72 AMG in October 2019.
Phone: +49 69 2475 778 40
Fax: +49 69 2475 778 49
Mail: info@8< SPAM-Schutz, bitte entfernen >8cansativa.de
We are available from Mo - Th between 9:00 a.m. and 6:00 p.m., Fr between 09:00 a.m. and 4:00 p.m.
You can also connect with us on Linked In: www.linkedin.com/company/cansativa-gmbh/
Benedikt Sons, Jakob Sons
Cansativa GmbH is registered as a limited liability company in the commercial register of the local court of Frankfurt am Main under HRB 108385